Genelux Corporation

The momentum for this stock is not very good. Genelux Corporation is not a good value stock. Genelux Corporation is not a good growth stock. Genelux Corporation is not very popular among insiders. Tradey thinks it is not wise to invest in Genelux Corporation.

News

Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference

Globe Newswire WESTLAKE VILLAGE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President...\n more…

Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells $211,949.10 in Stock

Ticker Report Genelux Co. (NASDAQ:GNLX - Get Free Report) major shareholder Aladar Szalay sold 107,045 shares of the company's stock in a transaction on Thursday, August 29th. The shares were sold at an average...\n more…

Roth Capital Weighs in on Genelux Co.'s Q3 2024 Earnings (NASDAQ:GNLX)

Ticker Report Genelux Co. (NASDAQ:GNLX - Free Report) - Research analysts at Roth Capital issued their Q3 2024 earnings estimates for Genelux in a report released on Tuesday, August 27th. Roth Capital analyst B...\n more…

Analysts Set Expectations for Genelux Co.'s Q3 2024 Earnings (NASDAQ:GNLX)

Zolmax Genelux Co. (NASDAQ:GNLX - Free Report) - Analysts at Roth Capital issued their Q3 2024 earnings estimates for Genelux in a research report issued to clients and investors on Tuesday, August 27th...\n more…

Have Genelux Insiders Been Selling Stock?

Simply Wall St Anyone interested in Genelux Corporation ( NASDAQ:GNLX ) should probably be aware that a company insider, Aladar...\n more…

Genelux started at buy by Roth MKM ahead of Olvi-Vec readouts

SeekingAlpha.com: All News Roth MKM started coverage of Genelux (GNLX) with a buy rating, citing the company's drug Olvi-Vec in the treatment of ovarian cancer. Read more here.\n more…